Invention Grant
- Patent Title: MAP kinase modulators and uses thereof
-
Application No.: US15697656Application Date: 2017-09-07
-
Publication No.: US10428047B2Publication Date: 2019-10-01
- Inventor: Ottavio Arancio , Daniel Martin Watterson , Jeffrey Claude Pelletier , Saktimayee Mitra Roy
- Applicant: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK , Northwestern University
- Applicant Address: US NY New York US IL Evanston
- Assignee: The Trustees of Columbia University in the City of New York,Northwestern University
- Current Assignee: The Trustees of Columbia University in the City of New York,Northwestern University
- Current Assignee Address: US NY New York US IL Evanston
- Agency: Wilmer Cutler Pickering Hale and Dorr LLP
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D401/04 ; A61P25/28
Abstract:
The invention provides for novel MAP kinase inhibitors and compositions comprising the same. In some embodiments, the MAP kinase inhibitors are p38α MAP kinase inhibitors. The invention further provides for methods for treatment of diseases comprising administration of MAP kinase inhibitors or compositions comprising MAP kinase inhibitors. In some embodiments, the disease is Alzheimer's Disease, ALS, Huntington's Disease or Parkinson's Disease.
Public/Granted literature
- US20170369472A1 MAP KINASE MODULATORS AND USES THEREOF Public/Granted day:2017-12-28
Information query
